Home/Smart Money/Euclidean Capital LLC
§ 13F · FUND PROFILE

Euclidean Capital LLC.

AUM · $440M (13F)Positions · 11Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$9M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS

The book · Q2 2026

FILED AUG 14, 2026
#TickerNameShares$ value% portΔ Q2
1VEUVANGUARD INTL EQUITY INDEX F3.24M$272M61.8%±0%
2VTVVANGUARD INDEX FDS520K$113M25.8%±0%
3INDAISHARES TR370K$18M4.2%±0%
4ORICORIC PHARMACEUTICALS INC989K$11M2.4%±0%
5TMSTEAMSHARES INC1.10M$9M2.1%NEW
6FHTXFOGHORN THERAPEUTICS INC1.57M$8M1.7%±0%
7PMVPPMV PHARMACEUTICALS INC2.63M$4M0.8%±0%
8ALECALECTOR INC1.31M$3M0.6%±0%
9SRZNSURROZEN INC88K$2M0.5%±0%
10TNYATENAYA THERAPEUTICS INC1.02M$751K0.2%±0%
§ 02 · SECTOR ALLOCATION

Where the money is

Sector data pending
§ 03 · THE EUCLIDEAN SIGNAL

AC read

Euclidean Capital LLC is a Other fund managing $440 million in assets. The fund runs a focused portfolio of just 11 positions.

Read the full dossier →